Workflow
化学原料和化学制品制造业
icon
Search documents
赞宇科技股价震荡,前三季度业绩增长近25%
Jing Ji Guan Cha Wang· 2026-02-12 04:38
Market Performance - Zanyu Technology (002637) experienced a volatile stock price movement from February 6 to February 11, 2026, with a cumulative increase of 1.75% and a fluctuation range of 8.15% [1] - On February 6, the stock price rose by 3.42% to 14.22 CNY, with a trading volume of 198 million CNY; on February 9, it fell by 3.73% to 13.69 CNY; and on February 11, it increased by 3.17% to 13.99 CNY, with a trading volume of 173 million CNY [1] - The net inflow of main funds was 6.0086 million CNY, indicating a recent trend of net inflow from institutional investors [1] Financial Performance - For the period from January to September 2025, Zanyu Technology reported an operating revenue of 9.676 billion CNY, representing a year-on-year growth of 27.92% [2] - The net profit attributable to the parent company was 151 million CNY, reflecting a year-on-year increase of 24.96% [2] - The main business segments include oil chemical products, accounting for 52.21%, and surfactants, accounting for 45.59%, with growth driven by increased demand for chemical products [2] Dividend Policy - Since its listing, the company has distributed a total of 637 million CNY in dividends, with 149 million CNY distributed over the past three years, demonstrating stable profitability [2]
四川泸天化股份有限公司 关于使用公积金弥补全部亏损的公告
Sou Hu Cai Jing· 2026-02-12 04:25
证券代码:000912 证券简称:泸天化 公告编号:2026-004 四川泸天化股份有限公司 关于使用公积金弥补全部亏损的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整,没有虚假记载、误导性陈述或重大遗漏。 四川泸天化股份有限公司(以下简称"公司")于2026年2月11日召开第八届董事会第十七次临时会议, 审议通过了《关于拟使用公积金弥补全部亏损的议案》,公司拟按照相关规定使用盈余公积金和资本公 积金弥补全部亏损,进一步推动公司符合法律法规和《四川泸天化股份有限公司章程》(以下简 称"《公司章程》")规定的利润分配条件。该议案尚需提交公司股东会审议。现将具体情况公告如下: 一、本次使用公积金弥补亏损的基本情况 根据会计师事务所(特殊普通合伙)出具的《审计报告》,截至2024年12月31日,公司母公司报表口径 累计未分配利润为-940,643,625.24元,盈余公积为380,097,727.02元,资本公积为5,387,877,514.20元。公 司使用盈余公积补亏后,需使用资本公积继续补亏,资本公积中符合用于弥补亏损的金额可覆盖母公司 累计未分配利润负数。 公司母公司亏损的主要原因系公司以前年度 ...
成本端支撑偏强,盘面表现坚挺
Hua Tai Qi Huo· 2026-02-12 04:09
1. Report Industry Investment Rating - Not provided in the given content 2. Core View of the Report - The cost side of propylene has strong support, and the market performance is firm. The supply of propylene is expected to have a slight increase, while the demand follow - up may be limited due to high prices. The future trend mainly depends on the cost side and downstream demand. The strategy suggests a wait - and - see approach for the single - side trading, and there are no suggestions for inter - period and inter - variety trading [1][2] 3. Summary According to the Catalog 3.1 Propylene Basis Structure - Propylene main contract closing price is 6272 yuan/ton (+48), propylene East China spot price is 6430 yuan/ton (+0), propylene North China spot price is 6445 yuan/ton (+5), propylene East China basis is 158 yuan/ton (-48), and propylene Shandong basis is 173 yuan/ton (-43) [1] 3.2 Propylene Production Profit and Capacity Utilization - Propylene capacity utilization is 72% (+1%), China propylene CFR - Japan naphtha CFR is 213 US dollars/ton (-15), propylene CFR - 1.2 propane CFR is 76 US dollars/ton (-8), and import profit is - 385 yuan/ton (-49) [1] 3.3 Propylene Downstream Profit and Capacity Utilization - PP powder capacity utilization is 31% (-0.61%), production profit is - 245 yuan/ton (-5); epoxy propane capacity utilization is 70% (-3%), production profit is - 783 yuan/ton (-328); n - butanol capacity utilization is 85% (-2%), production profit is 422 yuan/ton (-53); octanol capacity utilization is 91% (+0%), production profit is 88 yuan/ton (-203); acrylic acid capacity utilization is 82% (-2%), production profit is 235 yuan/ton (+0); acrylonitrile capacity utilization is 69% (+0%), production profit is - 1252 yuan/ton (-55); phenol - acetone capacity utilization is 86% (-2%), production profit is - 716 yuan/ton (+0) [1] 3.4 Propylene Inventory - Propylene plant inventory is 40470 tons (-2320) [1]
大洋生物业绩预增,新材料项目与产能扩张引关注
Jing Ji Guan Cha Wang· 2026-02-12 03:50
Performance Overview - The company expects a net profit attributable to shareholders for 2025 to be between 96 million to 110 million yuan, representing a year-on-year growth of 50.60% to 72.56%, primarily driven by the increase in both volume and price of potassium carbonate and veterinary raw materials [2] Project Development - The company plans to invest 193 million yuan to establish a project with an annual production capacity of 2,000 tons of polyether ether ketone (PEEK) and key intermediates, aiming to enter the high-performance engineering plastics market and break foreign monopolies. This project is currently in the planning stage [3] Capacity Expansion - The company currently has an existing production capacity of 600 tons per year for hydrochloride amiphenazole, with an additional 800 tons per year under construction, expected to commence production in June 2026, which is anticipated to further enhance its market share in this business [4] Financial Situation - In January 2026, the company's stock price experienced fluctuations, with significant changes in capital flow, reflecting short-term market sentiment volatility. These changes may be influenced by the earnings forecast and sector rotation [5]
西陇科学(002584)投资者索赔获赔到位,后续可索赔时间已不多
Xin Lang Cai Jing· 2026-02-12 03:22
Core Viewpoint - West Long Science (002584) has been found guilty of financial misconduct, leading to a successful compensation case for investors, with ongoing opportunities for further claims as the statute of limitations approaches [1][2][3][4] Financial Misconduct Details - In 2020, West Long Science inflated its operating revenue by approximately 597.65 million yuan, costs by about 595.99 million yuan, and profits by around 1.66 million yuan, representing 9.57%, 10.34%, and 2.04% of total revenue, costs, and profits respectively [3][4] - In 2021, the company inflated its operating revenue by approximately 1.46 billion yuan, costs by about 1.44 billion yuan, and profits by around 13.48 million yuan, accounting for 21.32%, 22.98%, and 5.93% of total revenue, costs, and profits respectively [4] - In the first half of 2022, the inflated operating revenue was approximately 785.35 million yuan, costs were about 777.23 million yuan, and profits were inflated by around 8.12 million yuan, which represented 22.94%, 22.97%, and 8.98% of total revenue, costs, and profits respectively [4] Legal Proceedings and Investor Claims - A recent ruling by the Shantou Intermediate People's Court has resulted in a victory for investors, with compensation already disbursed [1][2] - Investors who purchased West Long Science shares between April 29, 2021, and April 29, 2023, and sold or held their shares after April 29, 2023, are still eligible to file claims, but the time frame for doing so is limited to less than three months [2][4]
天际股份遭证监会立案 投资者或可索赔
Xin Lang Cai Jing· 2026-02-12 03:17
Core Viewpoint - Tianji Co., Ltd. is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, following previous findings of irregularities in goodwill impairment testing, financial accounting, and information disclosure [1][4]. Group 1: Regulatory Actions - On February 11, 2026, Tianji Co., Ltd. received a notice from the CSRC regarding the initiation of an investigation due to suspected violations of securities laws [1][4]. - On January 15, 2026, the company disclosed that the Guangdong Securities Regulatory Bureau had identified several violations, including non-standard goodwill impairment testing and inaccurate financial accounting [4]. Group 2: Financial Performance - The company forecasted a net profit of between 70 million and 105 million yuan for the fiscal year 2025, a significant turnaround from a loss of 1.361 billion yuan in the previous year [2][4]. - Since late August 2025, the stock price of Tianji Co., Ltd. surged from below 10 yuan to a peak of 55.98 yuan, although it has recently experienced a decline [2][4]. Group 3: Investor Implications - Investors who purchased shares of Tianji Co., Ltd. before January 11, 2026, and sold or held them after January 12, 2026, may be eligible for compensation due to the ongoing investigation [3][5].
怡达股份澄清无TMP产品,股价受行业价格波动影响
Jing Ji Guan Cha Wang· 2026-02-12 03:14
Group 1 - The core viewpoint of the news is that Yida Co., Ltd. (300721) clarified on its interactive platform that the company does not have TMP products, which helps to eliminate potential market misunderstandings [1] - The epoxy propylene sector experienced a significant price increase in January due to adjustments in export tax policies, with Yida Co., Ltd. seeing a stock price increase of 37.78% in January [1] - However, in early February, industry prices began to correct, leading to market concerns regarding changes in supply and demand dynamics [1] Group 2 - In the recent stock performance, Yida Co., Ltd. showed notable volatility over the past week (February 5 to February 11, 2026), with a slight decline of 0.12% and a fluctuation range of 12.45% [2] - On February 9, the stock price rose by 3.95% to 17.39 yuan, with a trading volume of 436 million yuan; however, it fell by 4.03% to 16.69 yuan on February 10 and further decreased by 1.98% to 16.36 yuan on February 11, indicating a net outflow of 4.5485 million yuan in principal funds [2] - The turnover rate remained high, indicating active short-term trading [2]
芳烃橡胶早报-20260212
Yong An Qi Huo· 2026-02-12 02:38
Report Summary 1. Report Industry Investment Rating No relevant information provided. 2. Core Views - For PTA, recent TA has turned to inventory accumulation, with its processing fees and PXN compressed. Considering the improved cash - flows of downstream sectors, limited PX supply increase at current valuations, and no significant load - up of TA plants, the valuation is becoming more reasonable. One can focus on phased positive spreads and long - allocation opportunities [2]. - For MEG, after the recent valuation of EG has been compressed again, the reduction in supply has further increased. Although short - term inventory accumulation continues, the certainty of inventory drawdown in the far - month is rising. During the production - expansion cycle, the overall elasticity is limited. One can focus on short - term put - selling opportunities [2]. - For polyester staple fiber, the downstream of staple fiber is expected to continue to weaken seasonally, and it has entered the pre - holiday load - reduction stage. The absolute inventory pressure is not large, with a low - to - medium valuation and weak driving force, and overall contradictions are limited. One should pay attention to the situation of warehouse receipts [2]. - For natural rubber, the main strategy is to wait and see [4]. 3. Summary by Product PTA - **Price and Basis**: The average daily basis of PTA spot transactions is 2605(-63). The basis has strengthened slightly, and the spot processing fee has weakened month - on - month. - **Device Changes**: Dushan Energy's 2.5 - million - ton plant is under maintenance. - **Supply and Demand**: Near - term TA plants have resumed operation, and the operating rate has increased month - on - month. Polyester load has continued to decline, and inventory has continued to accumulate [2]. MEG - **Price and Basis**: The basis of MEG spot transactions is around 05(-113). The basis has weakened slightly, and coal - based profits have shrunk. - **Device Changes**: Shanxi Wonen's 300,000 - ton plant is under maintenance. - **Supply and Demand**: Near - term domestic oil - based plants have resumed operation while coal - based plants are under maintenance. The overall operating rate has increased slightly, port inventory has continued to be obvious at the beginning of next week, and the forecast of arrivals this week has declined slightly [2]. Polyester Staple Fiber - **Price and Basis**: The spot price is around 6592, and the market basis is around 03 - 50. - **Device Changes**: There is no information on device maintenance this week. - **Supply and Demand**: Near - term plant maintenance before the holiday has continued, the operating rate has further declined to 77.7%, sales have remained weak, inventory has accumulated month - on - month, and spot processing fees have improved month - on - month. The operating rate on the polyester yarn side has continued to decline, raw material inventory and finished - product inventory have remained stable, and profits have remained the same month - on - month [2]. Natural Rubber - **Price Changes**: The weekly changes of some varieties are as follows: the price of US - dollar - denominated Thai standard rubber has increased by 10, Thai mixed rubber by 5, Shanghai full - latex rubber by 70, and the RU main contract by 190. - **Spread Changes**: The weekly changes of some spreads are as follows: the spread between mixed rubber and RU main contract has increased by 30, the spread between US - dollar - denominated Thai standard rubber and NR main contract by 79, and the spread between full - latex and mixed rubber by 90. - **Strategy**: The main strategy is to wait and see [4]. Styrene - **Raw Material and Product Prices**: The prices of ethylene (CFR Northeast Asia) have remained stable at 690. The price of pure benzene (CFR China) has decreased slightly, and the price of styrene (CFR China) has increased by 5 on a daily basis. - **Profit Changes**: The domestic profit of styrene has remained at 464, and the domestic profit of EPS has decreased by 15 on a daily basis [9].
坤彩科技股价异常波动,2025年预亏,2026年产能计划引关注
Jing Ji Guan Cha Wang· 2026-02-12 01:32
在2026年2月9日的投资者活动中,公司表示钛白粉和氧化铁业务预计随行业价格回升在2026年改善,并 计划在第二季度将氯化钛白产能提升至约2万吨/月,以发挥规模效应。 机构调研 公司近期举办现场交流,强调珠光材料高端化进展和成本管控。 业绩经营情况 公司已于2026年1月30日发布业绩预亏公告,预计2025年全年归母净利润亏损6500万至8500万元,主要 因子公司资产减值。正式经审计的年报计划在2026年初披露。 公司项目推进 经济观察网坤彩科技(603826)近期因股价异常波动引发市场关注,同时披露2025年业绩预亏及2026年 业务与产能计划。 股票近期走势 公司于2026年2月5日发布公告,因连续三个交易日(2月3日至5日)收盘价格涨幅偏离值累计超过20%,属 于异常波动情形。公司自查表明生产经营正常,无未披露重大事项。 以上内容基于公开资料整理,不构成投资建议。 ...
红宝丽2025年业绩预降,子公司项目进入试生产准备
Jing Ji Guan Cha Wang· 2026-02-12 01:32
Core Viewpoint - Hongbaoli (002165.SZ) expects a significant decline in net profit for 2025, projecting a decrease of 58.97% to 72.65% due to factors such as raw material prices, exchange rates, and impairment provisions for subsidiary projects [1][2]. Financial Performance - The company forecasts that the net profit attributable to shareholders for 2025 will range from 16 million to 24 million yuan, reflecting a year-on-year decline of 58.97% to 72.65% [2]. Project Development - Hongbaoli announced that its subsidiary, Taixing Chemical, has completed the necessary procedures for the epoxy propylene comprehensive technology renovation project, which has entered the preliminary preparation stage for trial production. However, there is uncertainty regarding the timeline from trial production to the output of qualified products [3]. Regulatory Situation - On December 12, 2025, Hongbaoli received a warning letter from the Jiangsu Securities Regulatory Bureau for failing to disclose related party fund occupation and errors in annual report data, and was criticized by the Shenzhen Stock Exchange. These violations have been recorded in the integrity archives of the securities and futures market [4].